JTO Clin Res Rep 2024 Feb
The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC.
Related Questions
What is your preference?
New answer by Medical Oncologist at Georgetown University Hospital (July 5, 2025)
Biopsy (both liquid and tissue) can be informative - especially to ensure there is no histologic transformation to small cell or squamous cell - so I try this when feasible. I...